VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
EVAX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
EVAXEvaxion Biotech A/S
$2.54$16M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksEVAXQuarterly Financials

Evaxion Biotech A/S (EVAX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Evaxion Biotech A/S (EVAX) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

EVAX Income Statement

Quarterly statement

EVAX Income Statement

Evaxion Biotech A/S (EVAX) annual income statement — 8-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue0007.49M37K0122K3.02M154K51K73K000000000
Revenue Growth %-100%--100%148.33%-75.97%-100%67.12%-------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit0007.49M37K0122K3.02M154K51K73K000000000
Gross Margin %---100%100%-100%100%100%100%100%---------
Gross Profit Growth %-100%--100%148.33%-75.97%-100%67.12%-------------
Operating Expenses3.84M3.82M4.05M4.47M4.38M3.87M4.15M4.75M4.74M4.45M4.44M5.76M5.68M6.53M6.53M6.08M6.26M6.4M7.72M5.91M
OpEx % of Revenue---59.66%11829.73%-3398.36%157.37%3074.68%8719.61%6078.08%---------
Selling, General & Admin1.51M1.52M1.19M1.38M2.21M1.71M1.59M2.13M1.98M1.61M1.86M2.93M2.74M2.45M2.31M2.02M2.15M1.59M1.5M1.5M
SG&A % of Revenue---18.38%5978.38%-1302.46%70.73%1287.66%3158.82%2553.42%---------
Research & Development2.33M2.3M2.56M3.09M2.17M2.16M2.25M2.61M2.75M2.84M2.3M2.83M2.94M3.85M4.07M4.07M4.11M4.8M6.15M4.42M
R&D % of Revenue---41.27%5851.35%-1848.36%86.64%1787.01%5560.78%3147.95%---------
Other Operating Expenses00301K1K00302K000275K00221K142K00071K0
Operating Income-3.84M-3.82M-4.05M3.02M-4.34M-3.87M-4.02M-1.73M-4.58M-4.4M-4.36M-5.76M-5.68M-6.53M-6.53M-6.08M-6.26M-6.4M-7.72M-5.91M
Operating Margin %---40.34%-11729.73%--3298.36%-57.37%-2974.68%-8619.61%-5978.08%---------
Operating Income Growth %11.51%1.27%-0.7%274.58%5.26%12.01%7.79%69.96%19.31%32.63%33.12%5.28%9.3%-1.97%15.49%-2.89%10.92%-23.65%-66.22%-26.19%
EBITDA-3.84M-3.51M-8.29M5.71M-4.79M-1.38M-3.93M-1.65M-6.17M1.22M-4.25M-5.56M-5.69M-6.11M-5.95M-5.38M-4.72M-5.88M-7.73M-5.62M
EBITDA Margin %---76.24%-12932.43%--3223.98%-54.59%-4007.79%2396.08%-5820.55%---------
EBITDA Growth %19.74%-155.49%-110.64%446.81%22.47%-212.52%7.43%70.39%-8.53%120%28.64%-3.38%-20.49%-3.89%22.99%4.34%32.5%-39.9%-67.48%-22.66%
D&A (Non-Cash Add-back)00000090.75K000115K200K00571K00000
EBIT-3.84M-3.51M-8.29M5.71M-4.79M-1.38M-5.61M-1.65M-6.17M1.22M-4.59M-5.69M-5.69M-6.11M-7.17M-5.38M-4.72M-5.88M-7.73M-5.62M
Net Interest Income-129.82K-27K-3.79M1.33M-211K2.1M119.16K-300.95K-184K5.37M-418K-110K-174K-41K-524.2K168K1.31M361K672.2K237K
Interest Income30.95K305K-4.91M2.69M30K2.49M573.95K84.26K41K5.62M-250K72K47K285K70.56K703K1.54M519K744.01K288K
Interest Expense160.77K332K-1.12M1.36M241K397K454.79K385.21K225K246K168K182K221K326K594.77K535K225K158K71.81K51K
Other Income/Expense-86.88K-26K-2.12M1.33M-686K2.1M120K-300K-1.82M5.37M-336K-110K-231K90K-520K168K1.31M361K674K237K
Pretax Income-3.93M-3.85M-6.17M4.35M-5.03M-1.77M-3.9M-2.03M-6.4M976K-4.7M-5.87M-5.91M-6.43M-7.04M-5.92M-4.95M-6.04M-7.05M-5.67M
Pretax Margin %---58.09%-13583.78%--3200%-67.32%-4153.9%1913.73%-6438.36%---------
Income Tax-203.71K-216K-256K-265K-195K-192K-275K-96K-199K-218K-177K-194K-225K-194K-173K-175K-177K-247K1.32M-425K
Effective Tax Rate %5.19%5.62%4.15%-6.09%3.88%10.84%7.04%4.73%3.11%-22.34%3.77%3.3%3.81%3.01%2.46%2.96%3.58%4.09%-18.77%7.49%
Net Income-3.72M-3.63M-5.92M4.62M-4.83M-1.58M-3.63M-1.94M-6.2M1.19M-4.52M-5.68M-5.68M-6.24M-6.87M-5.74M-4.77M-5.79M-8.37M-5.25M
Net Margin %---61.64%-13056.76%--2974.59%-64.14%-4024.68%2341.18%-6195.89%---------
Net Income Growth %22.92%-129.68%-63.08%338.66%22.06%-232.33%19.77%65.92%-9.06%119.13%34.18%1.08%-19.19%-7.77%17.9%-9.33%30.08%-41.49%-96.29%-30.92%
Net Income (Continuing)-3.72M-3.63M-5.92M4.62M-4.83M-1.58M-3.63M-1.94M-6.2M1.19M-4.52M-5.68M-5.68M-6.24M-6.87M-5.74M-4.77M-5.79M-8.37M-5.25M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-9.00-0.44-0.894.20-4.40-0.50-3.40-1.40-4.601.04-6.60-8.20-8.40-9.68-11.40-9.64-8.00-10.00-15.44-10.92
EPS Growth %-104.55%12%73.82%400%4.35%-148.08%48.48%82.93%45.24%110.74%42.11%14.94%-5%3.2%26.17%11.72%44.44%-8.7%-46.77%-10.08%
EPS (Basic)-9.00-0.44-0.894.20-4.40-1.43-3.40-1.40-4.601.04-6.60-8.20-8.40-9.68-11.40-9.64-8.20-10.00-15.44-10.92
Diluted Shares Outstanding417.01K8.34M6.41M1.11M1.11M1.11M1.07M1.38M1.35M1.17M683.39K691.5K676.55K644.6K603.49K595.84K596K579.1K541.78K479.97K
Basic Shares Outstanding417.01K8.34M6.41M1.11M1.11M1.11M1.07M1.38M1.35M1.17M683.39K691.5K676.55K644.6K603.49K595.84K580.1K579.1K541.78K479.97K
Dividend Payout Ratio--------------------